1.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 13892, 2008-001727-65, TRIO-012, TRIO-CIRG-012, CP12-0606, I4T-IE-JVBC, NCT00703326
|
|
2.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 13893, 2008-005964-15, CP12-0715, I4T-IE-JVBD, NCT00917384
|
|
3.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 13921, 14T-IE-JVBP, CP12-0605, NCT00515697
|
|
4.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 13920, CP12-0604, NCT00533702
|
|
5.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 13922, CP12-0710, I4T-IE-JVBQ, NCT00627042
|
|
6.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 13924, CP18-0601, I4T-IE-JVBS, NCT00683475
|
|
7.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 13923, 2007-006717-17, CP12-0711, I4T-IE-JVBR, NCT00721162
|
|
8.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 13914, 2007-006715-22, CP12-0708, I4T-IE-JVBJ, NCT00735696
|
|
9.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 13897, 2008-004936-19, CP12-0709, I4T-IE-JVBH, NCT00862784
|
|
10.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: ABTC-0901 CDR0000641230, U01CA137443, ABTC-0901, IMCL-CP-19-0801, NCT00895180
|
|
11.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 13915, CP12-0712, I4T-IE-JVBK, NCT01017731
|
|
12.
|
Phase: Phase II Type: Treatment Status: Temporarily closed Age: 18 and over Sponsor: NCI Protocol IDs: ECOG-E7208, E7208, NCT01079780
|
|
13.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: 20 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 13898, CP12-0816, I4T-IE-JVBI, NCT01005355
|
|
14.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: 20 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 14204, CP12-1026, I4T-IE-JVBW, NCT01253525
|
|
15.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 20 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 14200, CP12-1028, I4T-IE-JVBX, NCT01256567
|
|
16.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: 20 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 14223, CP12-1029, 14T-IE-JVBY, NCT01286818
|